Article

Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in Argentina

2020-08-02

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and Aims</h4> Non-invasive biomarkers are urgently needed to identify patients with non-alcoholic fatty liver disease (NAFLD) especially those at risk of disease progression. This is particularly true in high prevalence areas such as Latin America. The gut microbiome and intestinal permeability may play a role in the risk of developing NAFLD and NASH, but the mechanism by which mic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 99f5807c-2ff8-58ac-bad4-672e9fdb1445
DOI: 10.1101/2020.07.30.20165308

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in ArgentinaDOI 10.1101/2020.07.30.20165308Read

Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype.Semantic proximity Read

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsSemantic proximity Read

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicitySemantic proximity Read

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read

Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease.Semantic proximity Read

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read

Multi-omics analysis reveals the impact of microbiota on host metabolism in hepatic steatosisSemantic proximity Read

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read